Deepali Sachdev - Concepedia

Author

Deepali Sachdev

University of Minnesota

Also Known As

D Sachdev, D. Sachdev, Deepali Sachdev, ] , D. Sachdev

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Minnesota University of Minnesota Medical Center Masonic Cancer Center Palmetto Hematology Oncology Sanofi (France)

About

Deepali Sachdev is an author at University of Minnesota specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.5K
2	Cell Biology	11	11	1.4K
3	Natural Sciences	4	4	303
4	Biochemistry	4	4	303
5	Cellular Physiology	1	1	53

Deepali Sachdev

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Disrupting insulin-like growth factor signaling as a potential cancer therapy Deepali Sachdev, Douglas Yee Molecular Cancer Therapeutics PathologyInsulin SignalingTumor BiologyOncologyPotential Cancer Therapy	2007	317
Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy Deepali Sachdev, Douglas Yee AACR Education book PathologyInsulin SignalingTumor BiologyOncologyPotential Cancer Therapy	2008	314
A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Deepali Sachdev, Shu Lian Li, Julie S. Hartell, PubMed Breast OncologyImmunologyIgf ActionImmunotherapyCancer Biology	2003	188
A Dominant Negative Type I Insulin-like Growth Factor Receptor Inhibits Metastasis of Human Cancer Cells Deepali Sachdev, Julie S. Hartell, Adrian V. Lee, Journal of Biological Chemistry Breast OncologyImmunologyCancer BiologyTumor BiologyFibroblast Growth Factor	2004	159
Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation Hua Zhang, Dedra H. Fagan, Xianke Zeng, Oncogene Cancer Cell ProliferationInsulin Receptor DownregulationMedicineInsulin ManagementTumor Suppressor	2010	122
Down-regulation of Insulin Receptor by Antibodies against the Type I Insulin-Like Growth Factor Receptor: Implications for Anti–Insulin-Like Growth Factor Therapy in Breast Cancer Deepali Sachdev, Rajeeva Singh, Yoko Fujita‐Yamaguchi, Cancer Research	2006	115
Solubility of Proteins Isolated from Inclusion Bodies Is Enhanced by Fusion to Maltose-Binding Protein or Thioredoxin Deepali Sachdev, John M. Chirgwin Protein Expression and Purification Protein ChemistryBiochemistryProtein AssemblyProtein FoldingMaltose-binding Protein	1998	108
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas Xin Huang, Haein Park, J.T. Greene, PLoS ONE High Risk SarcomasImmunologyImmunoeditingPathologyImmunotherapeutics	2015	106
Acquired Resistance to Tamoxifen Is Associated with Loss of the Type I Insulin-like Growth Factor Receptor: Implications for Breast Cancer Treatment Dedra H. Fagan, Ryan R. Uselman, Deepali Sachdev, Cancer Research	2012	101
The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival Deepali Sachdev, X Zhang, Ilze Matise, Oncogene MedicineCancer GrowthCancer BiologyCancer MetastasisPrimary Tumor Growth	2009	95

Page 1